192 related articles for article (PubMed ID: 1734031)
1. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
Odekon LE; Sato Y; Rifkin DB
J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
[TBL] [Abstract][Full Text] [Related]
2. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
5. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells.
Pepper MS; Sappino AP; Montesano R; Orci L; Vassalli JD
J Cell Physiol; 1992 Oct; 153(1):129-39. PubMed ID: 1522127
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P
J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424
[TBL] [Abstract][Full Text] [Related]
9. Urokinase in conditioned medium from phorbol ester-pretreated endothelial cells promotes polymorphonuclear leukocyte migration.
Odekon LE; Gilboa N; Del Vecchio P; Gudewicz PW
Circ Shock; 1992 Jun; 37(2):169-75. PubMed ID: 1511509
[TBL] [Abstract][Full Text] [Related]
10. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration.
Strand K; Murray J; Aziz S; Ishida A; Rahman S; Patel Y; Cardona C; Hammond WP; Savidge G; Wijelath ES
J Cell Biochem; 2000 Aug; 79(2):239-48. PubMed ID: 10967551
[TBL] [Abstract][Full Text] [Related]
11. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
Hasselaar P; Sage EH
J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
[TBL] [Abstract][Full Text] [Related]
12. The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro.
Schilling-Schön A; Pleyer U; Hartmann C; Rieck PW
Exp Eye Res; 2000 Dec; 71(6):583-9. PubMed ID: 11095910
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro.
Gajdusek CM; Luo Z; Mayberg MR
J Cell Physiol; 1993 Oct; 157(1):133-44. PubMed ID: 7691833
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R; Kumar S; Orci L; Pepper MS
Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
19. Zinc promotes the repair of wounded monolayers of cultured vascular endothelial cells.
Kaji T; Fujiwara Y; Sakurai S; Yamaoto C; Kozuka H; Koizumi F
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):189-98. PubMed ID: 8556273
[TBL] [Abstract][Full Text] [Related]
20. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G
J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
